{"id":"https://openalex.org/W2160030871","doi":"https://doi.org/10.1160/th15-05-0415","title":"Edoxaban: Impact on routine and specific coagulation assays","display_name":"Edoxaban: Impact on routine and specific coagulation assays","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-01","ids":{"openalex":"https://openalex.org/W2160030871","doi":"https://doi.org/10.1160/th15-05-0415","mag":"2160030871","pmid":"https://pubmed.ncbi.nlm.nih.gov/26510969"},"language":"en","primary_location":{"id":"doi:10.1160/th15-05-0415","doi":"https://doi.org/10.1160/th15-05-0415","is_oa":false,"landing_page_url":"https://doi.org/10.1160/th15-05-0415","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2160030871"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109892826","display_name":"Bernard Ch\u00e2telain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767857","display_name":"Namur Research Institute for Life Sciences","ror":"https://ror.org/038bmak92","country_code":"BE","type":"facility","lineage":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard Chatelain","raw_affiliation_strings":["Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, Universit\u00e9 Catholique de Louvain, Yvoir, Belgium","Namur Thrombosis and Hemostasis Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, Universit\u00e9 Catholique de Louvain, Yvoir, Belgium","institution_ids":["https://openalex.org/I4391767857","https://openalex.org/I95674353"]},{"raw_affiliation_string":"Namur Thrombosis and Hemostasis Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christian Chatelain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767857","display_name":"Namur Research Institute for Life Sciences","ror":"https://ror.org/038bmak92","country_code":"BE","type":"facility","lineage":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Chatelain","raw_affiliation_strings":["Hematology Department, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, Universit\u00e9 Catholique de Louvain, Yvoir, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, Universit\u00e9 Catholique de Louvain, Yvoir, Belgium","institution_ids":["https://openalex.org/I4391767857","https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078686392","display_name":"Jonathan Douxfils","orcid":"https://orcid.org/0000-0002-7644-5298","observed_orcids":["https://orcid.org/0000-0002-7644-5298"]},"institutions":[{"id":"https://openalex.org/I149768937","display_name":"University of Namur","ror":"https://ror.org/03d1maw17","country_code":"BE","type":"education","lineage":["https://openalex.org/I149768937"]},{"id":"https://openalex.org/I4391767857","display_name":"Namur Research Institute for Life Sciences","ror":"https://ror.org/038bmak92","country_code":"BE","type":"facility","lineage":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jonathan Douxfils","raw_affiliation_strings":["Jonathan Douxfils, Department of Pharmacy, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, B-5000, Belgium, E-mail: jonathan.douxfils@unamur.be"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jonathan Douxfils, Department of Pharmacy, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, B-5000, Belgium, E-mail: jonathan.douxfils@unamur.be","institution_ids":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041424887","display_name":"Jean\u2010Michel Dogn\u00e9","orcid":"https://orcid.org/0000-0003-2107-1804","observed_orcids":["https://orcid.org/0000-0003-2107-1804"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Michel Dogn\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000944048","display_name":"Fran\u00e7ois Mullier","orcid":"https://orcid.org/0000-0001-6947-6099","observed_orcids":["https://orcid.org/0000-0001-6947-6099"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fran\u00e7ois Mullier","raw_affiliation_strings":["D\u00e9partement de Sciences biom\u00e9dicales, Namur Thrombosis and Hemostasis Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Sciences biom\u00e9dicales, Namur Thrombosis and Hemostasis Center","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5078686392"],"corresponding_institution_ids":["https://openalex.org/I149768937","https://openalex.org/I4391767857"],"apc_list":null,"apc_paid":null,"fwci":9.1863,"has_fulltext":false,"cited_by_count":89,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98521997,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"115","issue":"02","first_page":"368","last_page":"381"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":1.0},{"id":"https://openalex.org/keywords/coagulation-testing","display_name":"coagulation tests","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6909999847412109},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9169999957084656},{"id":"https://openalex.org/keywords/prothrombin-time","display_name":"prothrombin time","score":0.9710000157356262},{"id":"https://openalex.org/keywords/thrombin-time","display_name":"thrombin time","score":0.6069999933242798},{"id":"https://openalex.org/keywords/thromboelastography","display_name":"thromboelastography","score":0.7799999713897705},{"id":"https://openalex.org/keywords/lupus-anticoagulant","display_name":"lupus anticoagulant","score":0.9449999928474426},{"id":"https://openalex.org/keywords/protein-s","display_name":"protein S","score":0.9150000214576721},{"id":"https://openalex.org/keywords/activated-protein-c-resistance","display_name":"activated protein C resistance","score":0.8220000267028809},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.9539999961853027},{"id":"https://openalex.org/keywords/thrombophilia","display_name":"thrombophilia","score":0.6959999799728394},{"id":"https://openalex.org/keywords/assay-standardization","display_name":"assay standardization","score":0.5989999771118164},{"id":"https://openalex.org/keywords/platelet-poor-plasma","display_name":"platelet-poor plasma","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.8692479133605957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7352343201637268},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.676183819770813},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.5052781701087952},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4837501049041748},{"id":"https://openalex.org/C2910877098","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Blood coagulation factors","level":3,"score":0.45229801535606384},{"id":"https://openalex.org/C3018972837","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin generation","level":4,"score":0.4161333441734314},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2909371852874756},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.20322376489639282},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.19970199465751648},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1991874873638153},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.14151528477668762},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.08235734701156616},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.06181052327156067},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D002138","descriptor_name":"Calibration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006487","descriptor_name":"Hemostasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010314","descriptor_name":"Partial Thromboplastin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010949","descriptor_name":"Plasma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011486","descriptor_name":"Protein C","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011517","descriptor_name":"Prothrombin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013818","descriptor_name":"Thermogravimetry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015951","descriptor_name":"Factor Xa","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016682","descriptor_name":"Lupus Coagulation Inhibitor","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017293","descriptor_name":"Protein S","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019851","descriptor_name":"Thrombophilia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1160/th15-05-0415","doi":"https://doi.org/10.1160/th15-05-0415","is_oa":false,"landing_page_url":"https://doi.org/10.1160/th15-05-0415","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:26510969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26510969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Journal Article"},{"id":"pmid:29890519","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29890519","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.unamur.be:openaire_cris_publications/bb777a28-ecac-40fe-955a-f3f581ad48b8","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.unamur.be/en/publications/bb777a28-ecac-40fe-955a-f3f581ad48b8","pdf_url":null,"source":{"id":"https://openalex.org/S4406922457","display_name":"Repository of the University of Namur","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Douxfils, J, Chatelain, B, Chatelain, C, Dogn\u00e9, J-M & Mullier, F 2015, 'Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide', Thrombosis and Haemostasis, vol. 115, no. 2, pp. 368-381. https://doi.org/10.1160/TH15-05-0415","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:173505","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/173505","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Thrombosis and Haemostasis : international journal for vascular biology and medicine, Vol. 115, no.2, p. 368-381 (2015)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":71,"referenced_works":["https://openalex.org/W1707073606","https://openalex.org/W1709315425","https://openalex.org/W1754932965","https://openalex.org/W1817520089","https://openalex.org/W1828520793","https://openalex.org/W1836026258","https://openalex.org/W1862944133","https://openalex.org/W1866866972","https://openalex.org/W1884576739","https://openalex.org/W1940756716","https://openalex.org/W1963968439","https://openalex.org/W1964424199","https://openalex.org/W1967129589","https://openalex.org/W1967893544","https://openalex.org/W1968973040","https://openalex.org/W1970676078","https://openalex.org/W1974024236","https://openalex.org/W1974709342","https://openalex.org/W1981340953","https://openalex.org/W1992780722","https://openalex.org/W1997637512","https://openalex.org/W1998433401","https://openalex.org/W2003433167","https://openalex.org/W2011157004","https://openalex.org/W2015940002","https://openalex.org/W2016754244","https://openalex.org/W2019960723","https://openalex.org/W2023363122","https://openalex.org/W2030594826","https://openalex.org/W2040812969","https://openalex.org/W2041979009","https://openalex.org/W2046144939","https://openalex.org/W2052233064","https://openalex.org/W2053361486","https://openalex.org/W2067666141","https://openalex.org/W2073510057","https://openalex.org/W2081081934","https://openalex.org/W2082107448","https://openalex.org/W2083861915","https://openalex.org/W2084030336","https://openalex.org/W2084904145","https://openalex.org/W2087630384","https://openalex.org/W2087879607","https://openalex.org/W2092563904","https://openalex.org/W2096246254","https://openalex.org/W2096361927","https://openalex.org/W2097854437","https://openalex.org/W2101669068","https://openalex.org/W2103196751","https://openalex.org/W2105644555","https://openalex.org/W2107151329","https://openalex.org/W2122652283","https://openalex.org/W2128811936","https://openalex.org/W2132953336","https://openalex.org/W2134819485","https://openalex.org/W2151514200","https://openalex.org/W2156970332","https://openalex.org/W2158014557","https://openalex.org/W2158105745","https://openalex.org/W2160625453","https://openalex.org/W2162070340","https://openalex.org/W2162508946","https://openalex.org/W2163853479","https://openalex.org/W2170260432","https://openalex.org/W2312859184","https://openalex.org/W2336533554","https://openalex.org/W2407139997","https://openalex.org/W2481569543","https://openalex.org/W2511296650","https://openalex.org/W2547958692","https://openalex.org/W2548076162"],"related_works":["https://openalex.org/W2894712992","https://openalex.org/W1967129589","https://openalex.org/W2312859184","https://openalex.org/W3092114878","https://openalex.org/W2073510057","https://openalex.org/W2977842889","https://openalex.org/W3104018099","https://openalex.org/W2124693396","https://openalex.org/W4223578292","https://openalex.org/W2412757059"],"abstract_inverted_index":{"Assessment":[0],"of":[1,4,35,44,90,102,138,147,155,168,216,222,234,251],"plasma":[2,61,205],"concentration/effect":[3],"edoxaban":[5,139,195],"may":[6,131,208],"be":[7,132,191,209,229],"useful":[8,31,133,210],"in":[9,59,219],"some":[10,187],"situations.":[11],"Also,":[12],"clinicians":[13],"need":[14],"to":[15,27,56,73,134,193,202,246],"know":[16],"how":[17],"routine":[18],"coagulation":[19,29],"assays":[20,118,173,175,199,227],"are":[21,149,180,200],"influenced.":[22],"It":[23],"was":[24,49,107,111],"our":[25],"aim":[26],"determine":[28],"tests":[30,93],"for":[32,41],"the":[33,42,64,114,128,136,145,153,178,204,220,235,238,242,252],"assessment":[34,154,250],"edoxaban's":[36],"pharmacodynamics":[37,137],"and":[38,86,105,122,144,166,174,241],"provide":[39,247],"recommendations":[40],"interpretation":[43],"haemostasis":[45,91],"diagnostic":[46,92],"tests.":[47],"Edoxaban":[48,151],"spiked":[50],"at":[51,71,77],"concentrations":[52],"ranging":[53],"from":[54],"0":[55],"1,000":[57],"ng/ml":[58,70,76],"platelet-poor":[60],"which":[62],"covers":[63],"on-therapy":[65],"range":[66],"(from":[67],"\u00b1":[68,74],"25":[69],"Ctrough":[72],"170":[75],"Cmax).":[78],"aPTT,":[79,103],"PT,":[80],"dRVVT,":[81],"chromogenic":[82,117],"anti-Xa":[83,198],"assays,":[84],"TGA":[85,130,207],"a":[87,123,223,248],"large":[88],"panel":[89],"were":[94],"performed":[95],"using":[96],"several":[97],"reagents.":[98,115],"A":[99],"concentration-dependent":[100],"prolongation":[101],"PT":[104,188],"dRVVT":[106],"observed.":[108],"The":[109],"effect":[110],"dependent":[112],"on":[113,127],"FXa":[116,179],"showed":[119],"high":[120],"sensitivity":[121],"linear":[124],"correlation":[125],"depending":[126],"methodology.":[129],"assess":[135,203],"but":[140,211],"its":[141],"turnaround":[142],"time":[143,236],"lack":[146],"standardisation":[148],"limitations.":[150],"impairs":[152],"lupus":[156],"anticoagulant,":[157],"protein":[158],"S":[159],"(clotting":[160],"method),":[161],"APC-R,":[162],"antithrombin":[163],"(FXa-based":[164],"assay)":[165],"measurement":[167],"clotting":[169],"factor":[170],"activity.":[171,196],"Immunological":[172],"acting":[176],"below":[177],"not":[181],"influenced":[182],"by":[183],"edoxaban.":[184],"In":[185,214],"conclusion,":[186],"reagents":[189],"could":[190],"used":[192],"estimate":[194],"Chromogenic":[197],"required":[201],"concentration.":[206],"requires":[212],"standardisation.":[213],"case":[215],"thrombophilia":[217],"or":[218],"exploration":[221],"haemorrhagic":[224],"event,":[225],"immunological":[226],"should":[228],"recommended,":[230],"when":[231],"applicable.":[232],"Standardisation":[233],"between":[237],"last":[239],"intake":[240],"sampling":[243],"is":[244],"mandatory":[245],"proper":[249],"result.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2160030871","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
